Our business strategy

We develop novel products in areas of high unmet health needs,to deliver treatments and relieve suffering for longer, healthier lives.

Medicinal plants with a history of use

  • Reduces development cost and time
  • Reduces risk
  • Pharmaceuticals and functional foods
  • Novel products

Balanced portfolio

  • High value products
  • Low cost, rapid development products (orphan pharmaceuticals, functional foods)
  • Human and veterinary markets
  • Early revenues

Virtual operation

  • Internal expertise with outsourced development activities
  • Reduces costs/maximises efficiency
  • Enhances collaboration with KSAs and specialist contractors worldwide
  • Enhances innovative partnering

KSA = Key Scientific Advisor

Partner with charitable organisations

  • Reduces development cost
  • Enhances collaboration with KSAs
  • Validates novel treatments for diseases with high unmet medical need and enhances value
  • Non-dilutive funds